Zangmeister Cancer Center

Name

Zangmeister Cancer Center

Legal name

Zangmeister Cancer Center

Website

https://zangcenter.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Gynecologic Oncology (HLAKAFAF)

Keywords

• Oncology treatment services
• Cancer care
• Hematology services
• Gynecologic oncology
• Clinical research

Headquarters

HQ city

Columbus

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Patient Care Services: Revenue from providing medical oncology, hematology, gynecologic oncology, diagnostic imaging, pathology, pharmacy, and infusion services to cancer patients. Services billed through insurance including Medicare, Medicaid, and commercial payers.
2. Specialty Pharmacy: In-house specialty pharmacy providing oral oncolytic medications to patients, generating revenue through medication dispensing
3. Clinical Trial Services: Revenue from conducting clinical trials in partnership with Sarah Cannon Research Institute and through James Cancer Network affiliation

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Zangmeister Cancer Center is a community-based medical oncology, gynecologic oncology, and hematology practice that diagnoses and treats cancer and blood disorders in central Ohio. Founded in 2007, the center offers office consultations, chemotherapy and infusion therapy, clinical trial enrollment, diagnostic imaging, pathology, lab services, and supportive care across three Ohio locations staffed by 12 medical oncologists, 2 gynecologic oncologists, and 8 advanced practice providers.

Product overview

Zangmeister Cancer Center is a community-based medical oncology, gynecologic oncology, and hematology practice providing comprehensive cancer care. The center offers a unified suite of services including Medical Oncology (chemotherapy, immunotherapy, targeted therapies), Hematology, Gynecologic Oncology, advanced therapies (BiTE Therapy, Radioligand Therapy, Molecular-Targeted Therapy), Diagnostic Imaging, Pathology, Pharmacy, Specialty Infusion Services, Care Coordination, Clinical Trials, and Financial Support. The center operates as part of the American Oncology Network (AON) and maintains an affiliation with OSU James Cancer Network for access to academic expertise and clinical trials.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology Diagnosis and treatment of solid tumor cancers in adult patients through office consultations, chemotherapy, targeted therapy, immunotherapy, and infusion services delivered by board-certified medical oncologists.
• Gynecologic Oncology Specialized care for women with gynecologic cancers (ovarian, uterine, cervical, and other reproductive system cancers) delivered by fellowship-trained gynecologic oncologists.
• Hematology Diagnosis and treatment of blood disorders, including benign and malignant hematologic conditions, provided by hematology-trained oncologists.
• Clinical Trials and Research Patient enrollment in oncology clinical trials conducted through the Sarah Cannon Research Institute and the Ohio State University James Cancer Network, providing community-based access to investigational cancer therapies.
• Supportive Care Services Comprehensive support services for cancer patients including nurse navigators, social workers, dietitians, financial counselors, and the Colla Health supportive care platform.

Quantifiable outcome

• Community oncology settings deliver high-quality, high-value cancer care that equals or surpasses hospitals according to COA study
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Colla HealthcoreStrategic or Co-development Partner · 29 June 2026National partnership to expand behavioral health services for cancer patients in community settings. Colla Health provides specialized behavioral health support including therapeutic support, case management, and psychiatric oversight designed for cancer patients experiencing anxiety, depression, stress, and emotional challenges during treatment.
• Ohio State University Comprehensive Cancer Center – James Cancer NetworkcoreStrategic or Co-development Partner · 21 May 2026Zangmeister Cancer Center became an affiliate of The James Cancer Network, connecting community-based care with academic expertise. The affiliation expands access to clinical trials (500+), advanced therapies including CAR T-cell therapy, stem cell transplant evaluation, and subspecialty care while allowing patients to continue receiving care at the local Zangmeister location.
• Community Oncology Alliance (COA) - CPANminorGTM or Marketing Partner · 30 April 2024Launched local CPAN Chapter to support cancer patients and survivors and patient advocacy efforts. Chapter serves as platform for patients to discuss importance of local access to care and treatments.
• Sarah Cannon Research InstitutecoreStrategic or Co-development Partner · 19 April 2021Partnership to expand patient access to cutting-edge cancer research through clinical trials offered as part of Zangmeister's oncology services. Sarah Cannon is a global leader in community-based clinical trials having led more than 500 first-in-human clinical trials.
• American Oncology Network (AON)coreStrategic or Co-development Partner · 1 January 2019Zangmeister Cancer Center partnered with American Oncology Network to enhance technology, expand oral oncolytic outpatient pharmacy, pathology and central laboratory services, and enhance care management services. AON provides pharmaceutical purchasing strategies, human resources, revenue cycle, payer negotiations, and technology support.
• CanCareminorOthersPatient support organization providing emotional support and resources for cancer patients and their families.

Scale indicators3 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• The US Oncology Network (McKesson): Network of community oncology practices supported by McKesson with shared technology, drug purchasing, and clinical-trial infrastructure. Operationally analogous to the AON-Zangmeister relationship and serves the same end market.
• Tennessee Oncology: Large community-based oncology practice offering medical oncology, hematology, gyn oncology, infusion, imaging, and clinical trials across Tennessee. Closely mirrors Zangmeister's multi-site, multi-specialty community model with similar service breadth.
• Sarah Cannon Research Institute: Zangmeister's clinical-trial partner since 2021. Sarah Cannon runs the largest community-based oncology trials network in the US and represents a structural peer in delivering research-enabled community cancer care.
• New York Oncology Hematology: US Oncology Network-affiliated community oncology practice providing multi-specialty cancer care across upstate New York. Operates under a similar affiliated-network structure with shared services and clinical-trial access.
• Florida Cancer Specialists & Research Institute: One of the largest US community oncology practices offering medical oncology, hematology, advanced therapies, imaging, lab, pharmacy, and a robust clinical trials program. Highly comparable service stack and patient-acquisition model.
• American Oncology Network: Zangmeister's parent network and operational partner since 2019. AON represents 350+ providers across 21 states and provides pharmacy, lab, and revenue cycle services to community oncology sites — directly comparable in business model and scope.
• Virginia Oncology Associates: Multi-site community oncology practice offering medical oncology, hematology, advanced therapies, imaging, lab, and clinical trials. Highly comparable service stack and community delivery model.

Regional players

• Oncology Hematology Care (OHC): Community oncology practice serving Cincinnati and surrounding Ohio/Kentucky/Indiana communities. Operates the same model (medical onc, hem, gyn onc, infusion, clinical trials) in adjacent Ohio geography — direct Midwest peer.

Broad incumbents

• Cleveland Clinic Cancer Center: Major Ohio-based academic and health-system cancer program offering medical, surgical, and radiation oncology across the full continuum. Represents the broader incumbent set that community oncology practices compete against for patients and payer steerage.
• Ohio State University Comprehensive Cancer Center – James Cancer Hospital: Zangmeister's affiliation partner since 2026. The academic anchor in central Ohio; offers the full spectrum of cancer services including inpatient and serves as both referral partner and competitive incumbent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/zangcenter
• LinkedInlinkedin.com/company/the-mark-h.-zangmeister-cancer-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zangmeister Cancer Center